Last updated on October 2018

Study of FPA008 in Combination With Nivolumab in Patients With Selected Advanced Cancers

Brief description of study

This is a phase 1a/b single-arm, open-label study to evaluate safety, tolerability, PK, and clinical benefit of FPA008 in combination with nivolumab in patients with selected advanced cancers.

Clinical Study Identifier: NCT02526017

Contact Investigators or Research Sites near you

Start Over

Michael S Gordon, MD

Scottsdale Healthcare Hospitals DBA Honor Health
Scottsdale, AZ United States

Sandip Patel, MD

Moores UC San Diego Cancer Center
La Jolla, CA United States

Anthony El-Khoueiry, MD

Norris Comprehensive Cancer Center, University of Southern California
Los Angeles, CA United States

Alain Mita, MD

Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Center
Los Angeles, CA United States

Karen Kelly, MD

UC Davis Comprehensive Cancer Center
Sacramento, CA United States

Nicholas A Butowski, MD

University of California, San Francisco
San Francisco, CA United States

Sant P. Chawla, MD

Sarcoma Oncology Research Center
Santa Monica, CA United States

Zev A. Wainberg, MD

UCLA Hematology/Oncology- Santa Monica
Santa Monica, CA United States

Jose Lutzsky, MD

Mount Sinai Comprehensive Cancer Center
Miami Beach, FL United States

Medical Lead

H. Lee Moffitt Cancer Center and Research Institute
Tampa, FL United States

Bassel El-Rayes, MD

Emory University Hospital
Atlanta, GA United States

Nicklas Pfanzelter, MD

Rush University Medical Center
Chicago, IL United States

Jason J Luke, MD

University of Chicago Medical Center
Chicago, IL United States

Medical Lead

Indiana University Health Hospital
Indianapolis, IN United States

Mohammed Milhem, MD

University of Iowa Hospitals and Clinics
Iowa City, IA United States

John T. Hamm, MD

Norton Cancer Institute, Norton Healthcare Pavilion
Louisville, KY United States

Medical Lead

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Baltimore, MD United States

Frank S. Hodi, MD

Dana Farber Cancer Institute
Boston, MA United States

Amy M. Weise, MD

Karmanos Cancer Institute
Detroit, MI United States

Ding Wang, MD, PhD

Henry Ford Hospital
Detroit, MI United States

Michaela L. Tsai, MD

Allina Health, Virginia Piper Cancer Institute
Minneapolis, MN United States

Mateusz Opyrchal, MD, PhD

Roswell Park Cancer Institute
Buffalo, NY United States

Mariza Daras, MD

Memorial Sloan Kettering
New York, NY United States

Medical Lead

The Christ Hospital
Cincinnati, OH United States

Rachel Sanborn, MD

Providence Portland Medical Center
Portland, OR United States

Matthew Taylor, MD

Oregon Health and Science University
Portland, OR United States

Peter O'Dwyer, MD

Hospital of the University of Pennsylvania
Philadelphia, PA United States

Jennifer Johnson, MD

Thomas Jefferson University Hospital
Philadelphia, PA United States

James J. Lee, MD, PhD

University of Pittsburgh Cancer Institute, William M. Cooper Ambulatory Pavilion of the Hillman Cancer Center
Pittsburgh, PA United States

Carolyn Britten, MD

Hollings Cancer Center, Medical University of South Carolina
Charleston, SC United States

Emily Chan, MD

Henry-Joyce Cancer Clinic, Vanderbilt-Ingram Cancer Center,
Nashville, TN United States

Karen Fink, MD, PhD

Baylor Charles A. Sammons Cancer Center, Baylor University Medical Center
Dallas, TX United States

Muhammad S Beg, MD

University of Texas Southwestern Medical Center
Dallas, TX United States

Jay-Jiguang Zhu, MD

Mischer Neuroscience Associates, The University of Texas Health Science Center at Houston
Houston, TX United States

Sarina A. Piha-Paul, MD

The University of Texas MD Anderson Cancer Center
Houston, TX United States

Andrew Brenner, MD

Cancer Therapy & Research Center, University of Texas Health Science Center at San Antonio
San Antonio, TX United States

Drew W Rasco, MD

South Texas Accelerated Research Therapeutics, LLC
San Antonio, TX United States

Sunil Sharma, MD

Huntsman Cancer Institute
Salt Lake City, UT United States

John Thompson, MD

Seattle Cancer Care Alliance
Seattle, WA United States

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.